0
ARTICLE |

Serum Is Chemotactic for Retinal-Derived Glial Cells FREE

Eugene de Juan, MD; John S. Dickson, MS; Leonard Hjelmeland, PhD
[+] Author Affiliations

Accepted for publication Feb 12, 1988.

Reprint requests to Duke University Eye Center, Box 3802, Durham, NC 27710 (Dr de Juan).


Arch Ophthalmol. 1988;106(7):986-990. doi:10.1001/archopht.1988.01060140132040
Text Size: A A A
Published online

• Retinal glial cells participate in nearly all proliferative retinopathies. Little is known about factors that can stimulate these cells to migrate from the retina and proliferate. We cultured retinal glial cells from immature rats and observed the migratory and proliferative responses to serum (0% to 10%) and two of its components, platelet-derived growth factor (PDGF) (0 to 30 ng/mL) and fibronectin (0 to 20 mg/L). We found that 1% serum causes a fivefold increase in migration of the retinal glia and a 170% increase in proliferation over baseline. Fibronectin caused a threefold increase in migration at 30 mg/L, and PDGF caused a fourfold increase at 20 ng/mL, but only PDGF caused an increase in proliferation (300% at 10 ng/mL).

REFERENCES

Hamilton C, Chandler D, Klintworth G, et al:  A transmission and scanning electron microscopic study of surgically excised preretinal membrane proliferations in diabetes mellitus . Am J Ophthalmol 1982;;94:473-488.
Van Horn DL, Aaberg T, Machemer R:  Glial cell proliferation in human retinal detachment with massive periretinal proliferation . Am J Ophthalmol 1975;;80:1-23.
Clarkson JC, Green WR, Massof O:  A histopathologic review of 168 cases of preretinal membrane . Am J Ophthalmol 1977;;84:1-17.
De Juan E Jr, Lambert H, Machemer R:  Recurrent proliferations in macular pucker, diabetic retinopathy and retrolental fibroplasia-like disease after vitrectomy . Graefes Arch Clin Exp Ophthalmol 1985;;223:174-183.
De Juan E Jr, Machemer R, Hatchell D:  Ultrastructural and immunocytochemical study of glio-vascular membranes in proliferative diabetic retinopathy . Invest Ophthalmol Vis Sci 1985;;26:23.
Campochiaro PA, Jerdan JA, Glaser BM:  Serum contains chemoattractants for human retinal pigment epithelial cells . Arch Ophthalmol 1984;;102:1830-1833.
Bryan JA III, Campochiaro PA:  A retinal pigment epithelial cell-derived growth factor(s) . Arch Ophthalmol 1986;;104:422-425.
Campochiaro PA, Glaser BM:  Endothelial cells release a chemoattractant for retinal pigment epithelial cells in vitro . Arch Ophthalmol 1985;;103:1876-1880.
Campochiaro PA, Glaser BM:  Plateletderived growth factor is chemotactic for human retinal pigment epithelial cells . Arch Ophthalmol 1985;;103:576-579.
Campochiaro PA, Glaser BM:  Mechanisms involved in retinal pigment epithelial cell chemotaxis . Arch Ophthalmol 1986;;104:277-280.
Folkman J, Klagsbrun M:  Angiogenic factors . Science 1987;;235:442-447.
Rowen SL, Glaser BM:  Retinal pigment epithelial cells release a chemoattractant for astrocytes . Arch Ophthalmol 1985;;103:704-707.
Bressler JP, Grotendorst GR, Levitov C, et al:  Chemotaxis of rat brain astrocytes to platelet derived growth factor . Brain Res 1985;;344:249-254.
Burke JM:  Cultured retinal glial cells are insensitive to platelet-derived growth factor . Exp Eye Res 1982;;35:663-669.
Yeo J, Sadeghi J, Campochiaro P, et al:  Intravitreous fibronectin and platelet-derived growth factor . Arch Ophthalmol 1985;;104:417-421.
Grotendorst GR, Chang T, Seppa HEJ, et al:  Platelet-derived growth factor is a chemoattractant for vascular smooth muscle cells . J Cell Physiol 1982;;113:261-266.
Seppa H, Grotendorst G, Seppa S, et al:  Platelet-derived growth factor is chemotactic for fibroblasts . J Cell Biol 1982;;92:584-588.
Heldin CH, Westermark B, Wasteson A:  Specific receptors for platelet-derived growth factor on cells derived from connective tissue and glia . Proc Natl Acad Sci USA 1981;;78:3664-3668.
Martinet Y, Bitterman P, Mornex J, et al:  Activated human monocytes express the c-sis proto-oncogene and release a mediator showing PDGF-like activity . Nature 1986;;319:158-160.
Di Corleto P, Bowen-Pope D:  Cultured endothelial cells produce a platelet-derived growth factor-like protein . Proc Natl Acad Sci USA 1983;;80:1919-1923.
Rowen S, Glaser BM:  Endothelial cells release a stimulator of astrocyte migration . Invest Ophthalmol Vis Sci 1984;;25:273.

First Page Preview

First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Hamilton C, Chandler D, Klintworth G, et al:  A transmission and scanning electron microscopic study of surgically excised preretinal membrane proliferations in diabetes mellitus . Am J Ophthalmol 1982;;94:473-488.
Van Horn DL, Aaberg T, Machemer R:  Glial cell proliferation in human retinal detachment with massive periretinal proliferation . Am J Ophthalmol 1975;;80:1-23.
Clarkson JC, Green WR, Massof O:  A histopathologic review of 168 cases of preretinal membrane . Am J Ophthalmol 1977;;84:1-17.
De Juan E Jr, Lambert H, Machemer R:  Recurrent proliferations in macular pucker, diabetic retinopathy and retrolental fibroplasia-like disease after vitrectomy . Graefes Arch Clin Exp Ophthalmol 1985;;223:174-183.
De Juan E Jr, Machemer R, Hatchell D:  Ultrastructural and immunocytochemical study of glio-vascular membranes in proliferative diabetic retinopathy . Invest Ophthalmol Vis Sci 1985;;26:23.
Campochiaro PA, Jerdan JA, Glaser BM:  Serum contains chemoattractants for human retinal pigment epithelial cells . Arch Ophthalmol 1984;;102:1830-1833.
Bryan JA III, Campochiaro PA:  A retinal pigment epithelial cell-derived growth factor(s) . Arch Ophthalmol 1986;;104:422-425.
Campochiaro PA, Glaser BM:  Endothelial cells release a chemoattractant for retinal pigment epithelial cells in vitro . Arch Ophthalmol 1985;;103:1876-1880.
Campochiaro PA, Glaser BM:  Plateletderived growth factor is chemotactic for human retinal pigment epithelial cells . Arch Ophthalmol 1985;;103:576-579.
Campochiaro PA, Glaser BM:  Mechanisms involved in retinal pigment epithelial cell chemotaxis . Arch Ophthalmol 1986;;104:277-280.
Folkman J, Klagsbrun M:  Angiogenic factors . Science 1987;;235:442-447.
Rowen SL, Glaser BM:  Retinal pigment epithelial cells release a chemoattractant for astrocytes . Arch Ophthalmol 1985;;103:704-707.
Bressler JP, Grotendorst GR, Levitov C, et al:  Chemotaxis of rat brain astrocytes to platelet derived growth factor . Brain Res 1985;;344:249-254.
Burke JM:  Cultured retinal glial cells are insensitive to platelet-derived growth factor . Exp Eye Res 1982;;35:663-669.
Yeo J, Sadeghi J, Campochiaro P, et al:  Intravitreous fibronectin and platelet-derived growth factor . Arch Ophthalmol 1985;;104:417-421.
Grotendorst GR, Chang T, Seppa HEJ, et al:  Platelet-derived growth factor is a chemoattractant for vascular smooth muscle cells . J Cell Physiol 1982;;113:261-266.
Seppa H, Grotendorst G, Seppa S, et al:  Platelet-derived growth factor is chemotactic for fibroblasts . J Cell Biol 1982;;92:584-588.
Heldin CH, Westermark B, Wasteson A:  Specific receptors for platelet-derived growth factor on cells derived from connective tissue and glia . Proc Natl Acad Sci USA 1981;;78:3664-3668.
Martinet Y, Bitterman P, Mornex J, et al:  Activated human monocytes express the c-sis proto-oncogene and release a mediator showing PDGF-like activity . Nature 1986;;319:158-160.
Di Corleto P, Bowen-Pope D:  Cultured endothelial cells produce a platelet-derived growth factor-like protein . Proc Natl Acad Sci USA 1983;;80:1919-1923.
Rowen S, Glaser BM:  Endothelial cells release a stimulator of astrocyte migration . Invest Ophthalmol Vis Sci 1984;;25:273.

Correspondence

CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.